Here is more information on the trial in China. First patient was dosed Feb.2 2023 and the trial will be completed in a few months! Ignore the completion dates...1200 patients in 40 hospitals will recruit rapidly! https://www.clinicaltrials.gov/ct2/show/NCT05716425